Real-time enrollment status for this first episode psychosis (fep) clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 1:10 PM UTC
| NCT Number | NCT05509998 |
| Recruiting Status | Recruiting |
| Condition | First Episode Psychosis (FEP) |
| Phase | NA |
| Target Enrollment | 912 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | September 18, 2026 (Sep 18, 2026) |
As of October 18, 2026: Clinical trial NCT05509998 is currently recruiting participants. This na study for first episode psychosis (fep) is actively seeking new participants at 1 location across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05509998 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05509998 was last updated Sep 18, 2026 (September 18, 2026). HelloStudys verifies this status automatically.